Clinical Trial Update: Clinical Trial of Eye Prophylaxis in the Newborn [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating eye prophylaxis in newborns for preventing ophthalmia neonatorum and related chlamydia infections has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chlamydia Infections
• Ophthalmia Neonatorum

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Chlamydia Infections, Ophthalmia Neonatorum | Phase 3 | Status: COMPLETED